MedPath

Kures, Inc.

Kures, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2017-01-01
Employees
1
Market Cap
-
Website
http://www.kuresinc.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults

Phase 1
Completed
Conditions
Acute Pain
Interventions
Drug: OxyNorm
Drug: Placebo
First Posted Date
2021-11-09
Last Posted Date
2022-12-14
Lead Sponsor
Kures, Inc.
Target Recruit Count
60
Registration Number
NCT05114265
Locations
🇳🇿

KUR-101-101 Clinical Research Site, Christchurch, New Zealand

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.